Board of Advisors

Priv.-Doz. Dr. Katja Steiger

Priv.-Doz. Dr. Katja Steiger

Advisor Preclinics & Translation

Katja Steiger is the head of two research units at the Technical University of Munich (TUM), Institute of Pathology: The Comparative Experimental Pathology (CEP) and the Tissue Research Platform. She maintains numerous long-standing interdisciplinary collaborations, particularly with research groups focused on diagnostic imaging, such as radiology and nuclear medicine departments. Dr. Steiger has acquired an impressive academic record (216 peer-reviewed publications, cumulative IF >1550, as of March 2022). With her vast knowledge in morpho-molecular pathology across different species and in humans, she supports TRIMT in basic research activities as well as in translational and clinical projects.

Prof. Dr. Constantin Lapa

Prof. Dr. Constantin Lapa

Constantin Lapa studied medicine in Munich and finished his doctoral degree at the Ludwig-Maximilian University in 2011. In 2014, he reached the recognition as a nuclear medicine specialist and then completed his habilitation at the Julius-Maximilian University in Würzburg in 2017. From 2016, he served as a leading senior doctor at the Clinic and Polyclinic for Nuclear Medicine at the University Hospital in Würzburg till October 2019, since when he has been leading the Clinic for Nuclear Medicine at the University Hospital Augsburg. Prof. Lapa joined TRIMT's advisory board in mid 2022 and supports clinical translation of TRIMT pipeline with his exceptional expertise in evaluation of novel targeted radiotheranostics.

Prof. Dr. Marianne Patt

Prof. Dr. Marianne Patt

Marianne Patt leads the Radiopharmacy at the Clinic and Polyclinic for Nuclear Medicine at Leipzig University Hospital. She is a Qualified Person (QP) according to both European and national (German) regulations.

Prof. Patt is an influential member of the EANM and the DGN, two important professional societies in nuclear medicine. She chairs the EANM Radiopharmacy Committee and also contributes her expertise to the work group for radiopharmaceuticals of the German Federal Institute for Drugs and Medical Devices (BfArM).

Dr. Wolfgang Burger

Dr. Wolfgang Burger

Wolfgang Burger is leading the business of Lyomark Pharma from Oberhaching near Munich as CEO.- He studied chemistry and brings more than 30 years of experience in the field of API synthesis. At TRIMT, Dr. Burger brings above all his outstanding leadership and management skills, which he has already demonstrated in responsible positions for renowned companies such as Siegrid AG and PharmaZell GmbH.